(600276)"JIANGSU HENGRUI PHARMACEUTICALS CO., LTD."Announcement on Progress in Repurchasing A-Shares
Filed with SSE · Stock code 600276 · · 2 pages · Chinese
Summary by 6ix AI
Jiangsu Hengrui Pharmaceuticals Co., Ltd. has announced progress on its A-share repurchase plan. The repurchase is part of a strategy to implement an employee stock ownership plan and is in compliance with relevant regulations. The announcement includes details on the repurchase price range and total amount spent so far.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Jiangsu Hengrui Pharmaceuticals Co., Ltd. on 6ix
Story so far
Earlier from Jiangsu Hengrui Pharmaceuticals
- (600276)"JIANGSU HENGRUI PHARMACEUTICALS CO., LTD."Announcement on Receipt of the Drug Clinical Trial Approval Notice
- (600276)"JIANGSU HENGRUI PHARMACEUTICALS CO., LTD."Indicative Announcement on Acceptance by the EMA of the Application for Drug Marketing Authorization
- Jiangsu Hengrui Pharmaceuticals: Hengrui Pharma Announces EMA Validation of Marketing Authorisation Application for Wevdury (fuzuloparib) in Combination with Abiraterone for Metastatic Castration-Resistant Prostate Cancer
- Hengrui Pharma and Novo Enter Exclusive License Agreement for Once-Weekly Oral GLP-1/GIP Dual Receptor Agonist HRS-1596
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
Later from Jiangsu Hengrui Pharmaceuticals
- (600276)"JIANGSU HENGRUI PHARMACEUTICALS CO., LTD."Announcement on Obtaining Drug Registration Approval
- (600276)"JIANGSU HENGRUI PHARMACEUTICALS CO., LTD."Announcement on Resolutions of the 5th Meeting of the 10th Board of Directors
- (600276)"JIANGSU HENGRUI PHARMACEUTICALS CO., LTD."Report for Q3 2026
- (600276)"JIANGSU HENGRUI PHARMACEUTICALS CO., LTD."Indicative Announcement on Acceptance of Application for Drug Marketing Authorization and Inclusion in the Priority Review Program
- (600276)"JIANGSU HENGRUI PHARMACEUTICALS CO., LTD."Announcement on Resolutions of the 6th Meeting of the 10th Board of Directors
Follow Jiangsu Hengrui Pharmaceuticals into a list and get an email when it puts out news.
Follow Jiangsu Hengrui Pharmaceuticals